Rabbit Recombinant Monoclonal MCM5 antibody. Suitable for IHC-P, ICC/IF, IP, WB, Flow Cyt (Intra) and reacts with Human, Mouse samples. Cited in 17 publications.
View Alternative Names
CDC46, MCM5, DNA replication licensing factor MCM5, CDC46 homolog, P1-CDC46
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-MCM5 antibody [EP2683Y] (AB75975)
Immunocytochemistry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling MCM5 with Purified ab75975 at 1 : 50 dilution (2.1 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488,ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-MCM5 antibody [EP2683Y] (AB75975)
Intracellular Flow Cytometry analysis of MCF7 (Human breast adenocarcinoma epithelial cell) cells labeling MCM5 with Purified ab75975 at 1/20 dilution (10 μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488 ,ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MCM5 antibody [EP2683Y] (AB75975)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human tonsil tissue sections labeling MCM5 with purified ab75975 at 1/1000 dilution (0.11 µg/mL). Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). ImmunoHistoProbe one step HRP Polymer (ready to use) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- WB
Unknown
Western blot - Anti-MCM5 antibody [EP2683Y] (AB75975)
Blocking Buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-MCM5 antibody [EP2683Y] (ab75975) at 1/1000 dilution
Lane 1:
MCF7 (Human breast adenocarcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
Mouse spleen lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 82 kDa
Observed band size: 82 kDa
false
- WB
CiteAb
Western blot - Anti-MCM5 antibody [EP2683Y] (AB75975)
MCM5 western blot using anti-MCM5 antibody [EP2683Y] ab75975. Publication image and figure legend from Shao, Z., Koh, W., et al., 2020, Sci Rep, PubMed 32313136.
ab75975 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab75975 please see the product overview.
Validation of Two-week-old Mouse Heart RNA-Sequencing Results by RT-qPCR and Western Blot. RNA and protein samples analyzed were extracted from WT and Lmna-/- mouse heart tissues at 2 weeks of age. (a) RT-qPCR validation of down-regulated genes (AURKA, BRCA1, CDK1, CHEK1, Cyclin B1, MCM5, PLK1) identified by RNA-Sequencing. The housekeeping gene S18 was used as a control gene for both WT and Lmna-/- samples. ∆∆ cycle threshold (Ct) method was used for RT-qPCR analysis. Average WT expression level was normalized to one and Lmna-/- expression levels were calculated over average WT level and showed as "mean ± SEM" on Y axis. The expression levels of all the listed genes were significantly lower in 2-week Lmna-/- mouse hearts than in 2-week WT mouse hearts (p < 0.01). (b) RT-qPCR validation of up-regulated genes (EPHX1, NDUFA13, NRF2, PLK3, SQSTM1) identified by RNA-Sequencing. The same ∆∆Ct method was used for analysis. The relative expression levels of all the listed genes are showed as "mean ± SEM" on Y axis. The expression levels in 2-week-old Lmna-/- mouse hearts were significantly higher than those in 2-week-old WT mouse hearts for all the genes (p < 0.05). (c) Western blot validation of protein expressions of representative down-regulated (CDK1, Cyclin B1 and MCM5) and up-regulated (NRF2 and PLK3) genes. GAPDH was used as a loading control. Three repeated experiments were conducted for each protein with similar results showed in the figure.
false
Related conjugates and formulations (3)
-
Anti-MCM5 antibody [EP2683Y] - BSA and Azide free
-
421 Alexa Fluor® 405
Alexa Fluor® 405 Anti-MCM5 antibody [EP2683Y]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-MCM5 antibody [EP2683Y]
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Species reactivity
Rat: We have preliminary internal testing data to indicate this antibody may not react with this species.
Please contact us for more information.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
As a component of the MCM2-7 hexameric complex MCM5 contributes to the unwinding of DNA an essential step for replication. This complex acts as a helicase unwinding the DNA double helix at replication origins. This activity is required for laying down the replication fork and allowing access for the DNA polymerase. MCM5 integrates into the larger assembly of the replication machinery working in concert with cell cycle regulators to ensure proper cell cycle progression.
Pathways
MCM5 participates in DNA replication and cell cycle control pathways. It closely associates with the GINS complex and CDC45 forming the CMG (CDC45-MCM-GINS) complex which is critical for replication fork progression. MCM5 also interacts with the ATR-mediated DNA damage repair pathway. This relationship provides a checkpoint mechanism to halt replication in response to DNA damage allowing time for repair processes to maintain genomic stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 10: PubMed40059824
2025
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 25:242 PubMed37153049
2023
Applications
Unspecified application
Species
Unspecified reactive species
Genes & development 37:303-320 PubMed37024284
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of Cancer 14:262-274 PubMed36741260
2023
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 82:463-478.e11 PubMed34741808
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 9:669132 PubMed34409025
2021
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 4: PubMed33653688
2021
Applications
Unspecified application
Species
Unspecified reactive species
Life sciences 272:119227 PubMed33607151
2021
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 13:12015-12025 PubMed33244243
2020
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2020:3574261 PubMed32964028
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com